165 related articles for article (PubMed ID: 31746310)
21. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.
Bridgeman BB; Wang P; Ye B; Pelling JC; Volpert OV; Tong X
Cell Signal; 2016 May; 28(5):460-468. PubMed ID: 26876613
[TBL] [Abstract][Full Text] [Related]
23. Cell signaling pathways altered by natural chemopreventive agents.
Sarkar FH; Li Y
Mutat Res; 2004 Nov; 555(1-2):53-64. PubMed ID: 15476851
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
25. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes.
Tong X; Smith KA; Pelling JC
Mol Carcinog; 2012 Mar; 51(3):268-79. PubMed ID: 21538580
[TBL] [Abstract][Full Text] [Related]
26. The Potential Role of Apigenin in Cancer Prevention and Treatment.
Rahmani AH; Alsahli MA; Almatroudi A; Almogbel MA; Khan AA; Anwar S; Almatroodi SA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144783
[TBL] [Abstract][Full Text] [Related]
27. Anticancer properties of flavonoids: roles in various stages of carcinogenesis.
Clere N; Faure S; Martinez MC; Andriantsitohaina R
Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):62-77. PubMed ID: 21644918
[TBL] [Abstract][Full Text] [Related]
28. Apigenin blocks IKKα activation and suppresses prostate cancer progression.
Shukla S; Kanwal R; Shankar E; Datt M; Chance MR; Fu P; MacLennan GT; Gupta S
Oncotarget; 2015 Oct; 6(31):31216-32. PubMed ID: 26435478
[TBL] [Abstract][Full Text] [Related]
29. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin.
Jang JY; Sung B; Kim ND
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409117
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: mitochondria mediated apoptotic signalling cascades.
Das S; Das J; Samadder A; Paul A; Khuda-Bukhsh AR
Food Chem Toxicol; 2013 Dec; 62():670-80. PubMed ID: 24120900
[TBL] [Abstract][Full Text] [Related]
31. Reactive oxygen species: Key players in the anticancer effects of apigenin?
Oyenihi OR; Oyenihi AB; Alabi TD; Tade OG; Adeyanju AA; Oguntibeju OO
J Food Biochem; 2022 Feb; 46(2):e14060. PubMed ID: 34997605
[TBL] [Abstract][Full Text] [Related]
32. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
[TBL] [Abstract][Full Text] [Related]
33. Anti-mutagenic and pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells.
Hashemi M; Nouri Long M; Entezari M; Nafisi S; Nowroozii H
Acta Med Iran; 2010; 48(5):283-8. PubMed ID: 21287458
[TBL] [Abstract][Full Text] [Related]
34. Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives.
Salmani JMM; Zhang XP; Jacob JA; Chen BA
Chin J Nat Med; 2017 May; 15(5):321-329. PubMed ID: 28558867
[TBL] [Abstract][Full Text] [Related]
35. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
Hu WJ; Liu J; Zhong LK; Wang J
Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
[TBL] [Abstract][Full Text] [Related]
36. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
[TBL] [Abstract][Full Text] [Related]
37. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.
Rezai-Zadeh K; Ehrhart J; Bai Y; Sanberg PR; Bickford P; Tan J; Shytle RD
J Neuroinflammation; 2008 Sep; 5():41. PubMed ID: 18817573
[TBL] [Abstract][Full Text] [Related]
38. Apigenin prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.
Silvan S; Manoharan S
Arch Oral Biol; 2013 Jan; 58(1):94-101. PubMed ID: 22776109
[TBL] [Abstract][Full Text] [Related]
39. Plant flavone apigenin: An emerging anticancer agent.
Shankar E; Goel A; Gupta K; Gupta S
Curr Pharmacol Rep; 2017 Dec; 3(6):423-446. PubMed ID: 29399439
[TBL] [Abstract][Full Text] [Related]
40. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
Sen K; Banerjee S; Mandal M
Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
